Method
Level · gp.fundamentals.debt_to_revenue
Raw value 181.51% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTProfound Medical Corp.'s latest supported as-filed period reports revenue of $2.5M, 25.3% above the comparable as-filed period; gross margin moved 326 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 181.51% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -456.63% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 25.34% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 421.10% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 78.41% · CORE
Level · gp.fundamentals.operating_margin
Raw value -445.67% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 3 independently calculated changes: Revenue increased 25.3%; Operating margin moved 25125 bp higher; Operating income increased 19.8%.
3 evidence-backed componentsOperating margin changed +25125 basis points from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
PROF · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001171843-26-005868SEC ↗8-KAug 17, 2026Period Aug 17, 20260001171843-26-005580SEC ↗8-KAug 17, 2026Period Aug 14, 20260001171843-26-005575SEC ↗8-KAug 13, 2026Period Aug 13, 20260001171843-26-005500SEC ↗10-QAug 6, 2026Period Jun 30, 20260001104659-26-092066SEC ↗8-KAug 6, 2026Period Aug 6, 20260001171843-26-005322SEC ↗8-KJul 24, 2026Period Jul 24, 20260001171843-26-004863SEC ↗8-KTransaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 227.71% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 35.20% · OPTIONAL
Gross margin changed -326 basis points from the comparable as-filed period.
Net income changed +39.2% from the comparable as-filed period.
Revenue changed +25.3% from the comparable as-filed period.
Stock-based compensation changed -39.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +19.8% from the comparable as-filed period.
Inventory changed +25.2% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001171843-26-004740